Hib-MenC-CRM197 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hib-MenC-CRM197 vaccine, covering 2016-09-21 to 2016-09-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197 [Phase 3]